Literature DB >> 20016710

Effects of taurine supplementation on bone mineral density in ovariectomized rats fed calcium deficient diet.

Mi-Ja Choi1.   

Abstract

Taurine supplementation has been shown to have a beneficial effect on femur bone mineral content in ovariectomized rats. It therefore seemed desirable to find out whether the beneficial effect of taurine on ovariectomized rats fed calcium deficient diet could also be reproduced. Forty female Sprague-Dawley rats were divided into two groups. One group was OVX and the other group received sham operation (SHAM), and received either control diet or a taurine supplemented diet for 6 weeks. All rats were fed on calcium deficient diet (AIN-93: 50% level of calcium) and deionized water. Bone mineral density (BMD) and bone mineral content (BMC) were measured in spine and femur. The serum and urine concentrations of calcium and phosphorus were determined. Bone formation was measured by serum osteocalcin and alkaline phosphatase (ALP) concentrations. Bone resorption rate was measured by deoxypyridinoline (DPD) crosslinks immunoassay and corrected for creatinine. Urinary calcium and phosphorus excretion, osteocalcin in blood and cross link value were not significantly different among the groups. Within the OVX group, the taurine supplemented group had not higher femur bone mineral content than the control group. This study established the need for a study on the taurine effect on bone with different calcium levels.

Entities:  

Keywords:  BMD; OVX; Taurine; calcium deficient diet

Year:  2009        PMID: 20016710      PMCID: PMC2788169          DOI: 10.4162/nrp.2009.3.2.108

Source DB:  PubMed          Journal:  Nutr Res Pract        ISSN: 1976-1457            Impact factor:   1.926


  34 in total

1.  Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women.

Authors:  Christopher Jensen; Leah Holloway; Gladys Block; Gene Spiller; Ginny Gildengorin; Erica Gunderson; Gail Butterfield; Robert Marcus
Journal:  Am J Clin Nutr       Date:  2002-06       Impact factor: 7.045

Review 2.  Relationships among body mass, its components, and bone.

Authors:  I R Reid
Journal:  Bone       Date:  2002-11       Impact factor: 4.398

3.  Endurance training and bone loss in calcium-deficient and ovariectomized rats.

Authors:  H J Donahue; R S Mazzeo; S M Horvath
Journal:  Metabolism       Date:  1988-08       Impact factor: 8.694

4.  Lifetime milk consumption and bone mineral density in older women.

Authors:  S Soroko; T L Holbrook; S Edelstein; E Barrett-Connor
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

5.  Calcium intake and body weight.

Authors:  K M Davies; R P Heaney; R R Recker; J M Lappe; M J Barger-Lux; K Rafferty; S Hinders
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

6.  Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.

Authors:  P Ravn; G Cizza; N H Bjarnason; D Thompson; M Daley; R D Wasnich; M McClung; D Hosking; A J Yates; C Christiansen
Journal:  J Bone Miner Res       Date:  1999-09       Impact factor: 6.741

7.  Girls' calcium intake is associated with bone mineral content during middle childhood.

Authors:  Laura M Fiorito; Diane C Mitchell; Helen Smiciklas-Wright; Leann L Birch
Journal:  J Nutr       Date:  2006-05       Impact factor: 4.798

8.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Evidence for alteration of the vitamin D-endocrine system in obese subjects.

Authors:  N H Bell; S Epstein; A Greene; J Shary; M J Oexmann; S Shaw
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 10.  Clinical considerations in premenopausal osteoporosis.

Authors:  Margaret L Gourlay; Sue A Brown
Journal:  Arch Intern Med       Date:  2004-03-22
View more
  8 in total

Review 1.  Metabolomic biomarkers of low BMD: a systematic review.

Authors:  N Panahi; B Arjmand; A Ostovar; E Kouhestani; R Heshmat; A Soltani; B Larijani
Journal:  Osteoporos Int       Date:  2021-07-26       Impact factor: 4.507

2.  The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model.

Authors:  Hatem M Abuohashish; Mohammed M Ahmed; Salim S Al-Rejaie; Kamal E H Eltahir
Journal:  Acta Pharmacol Sin       Date:  2014-12-29       Impact factor: 6.150

3.  When Incorporated into Fruit Sorbet Matrix, Are the Fructans in Natural Raw Materials More Beneficial for Bone Health than Commercial Formulation Added Alone?

Authors:  Kinga Topolska; Marek Bienko; Paweł Ptaszek; Adam Florkiewicz; Radoslaw P Radzki; Agnieszka Filipiak-Florkiewicz
Journal:  Animals (Basel)       Date:  2022-04-28       Impact factor: 3.231

4.  Taurine, an osteocyte metabolite, protects against oxidative stress-induced cell death and decreases inhibitors of the Wnt/β-catenin signaling pathway.

Authors:  M Prideaux; Y Kitase; M Kimble; T M O'Connell; L F Bonewald
Journal:  Bone       Date:  2020-04-21       Impact factor: 4.398

5.  Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis.

Authors:  Hatem M Abuohashish; Mohammed M Ahmed; Dina Sabry; Mahmoud M Khattab; Salim S Al-Rejaie
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

6.  Metabolomic profiles associated with bone mineral density in US Caucasian women.

Authors:  Qi Zhao; Hui Shen; Kuan-Jui Su; Ji-Gang Zhang; Qing Tian; Lan-Juan Zhao; Chuan Qiu; Qiang Zhang; Timothy J Garrett; Jiawang Liu; Hong-Wen Deng
Journal:  Nutr Metab (Lond)       Date:  2018-08-10       Impact factor: 4.169

7.  Proteomics Analysis to Identify and Characterize the Molecular Signatures of Hepatic Steatosis in Ovariectomized Rats as a Model of Postmenopausal Status.

Authors:  Chen-Chung Liao; Yen-Shuo Chiu; Wan-Chun Chiu; Yu-Tang Tung; Hsiao-Li Chuang; Jyh-Horng Wu; Chi-Chang Huang
Journal:  Nutrients       Date:  2015-10-22       Impact factor: 5.717

8.  A tailored polylactic acid/polycaprolactone biodegradable and bioactive 3D porous scaffold containing gelatin nanofibers and Taurine for bone regeneration.

Authors:  Hadi Samadian; Saeed Farzamfar; Ahmad Vaez; Arian Ehterami; Arindam Bit; Mostafa Alam; Arash Goodarzi; Gholamhossein Darya; Majid Salehi
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.